| pubmed-article:10029486 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10029486 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10029486 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
| pubmed-article:10029486 | lifeskim:mentions | umls-concept:C0152459 | lld:lifeskim |
| pubmed-article:10029486 | lifeskim:mentions | umls-concept:C0009905 | lld:lifeskim |
| pubmed-article:10029486 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:10029486 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10029486 | pubmed:dateCreated | 1999-4-16 | lld:pubmed |
| pubmed-article:10029486 | pubmed:abstractText | A case of striae distensae (SD) of bilateral augmented breasts following oral contraceptive therapy is presented. Striae maturation and the prevention of additional skin marks was achieved with immediate cessation of oral contraceptive pill therapy and long-term daily topical application of tretinoin cream. It is suggested that patients who are candidates for breast augmentation surgery should be informed of the possible risk of developing SD if they are taking or planning to take the contraceptive pill. | lld:pubmed |
| pubmed-article:10029486 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10029486 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10029486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10029486 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10029486 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10029486 | pubmed:issn | 0148-7043 | lld:pubmed |
| pubmed-article:10029486 | pubmed:author | pubmed-author:WeissmanAA | lld:pubmed |
| pubmed-article:10029486 | pubmed:author | pubmed-author:Har-ShaiYY | lld:pubmed |
| pubmed-article:10029486 | pubmed:author | pubmed-author:BarakAA | lld:pubmed |
| pubmed-article:10029486 | pubmed:author | pubmed-author:TaranAA | lld:pubmed |
| pubmed-article:10029486 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10029486 | pubmed:volume | 42 | lld:pubmed |
| pubmed-article:10029486 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10029486 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10029486 | pubmed:pagination | 193-5 | lld:pubmed |
| pubmed-article:10029486 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10029486 | pubmed:otherAbstract | PIP: This is a descriptive report on the development of striae distensae (SD) on augmented breasts following oral contraceptive (OC) therapy. The subject was a 17-year-old nulliparous girl who had undergone bilateral augmentation mammoplasty and developed SD following low-dose OC therapy for 4 months after surgery. The pathogenesis of SD seems to be multifactorial and includes mechanical stretching, age, hormonal effects, and genetic and familial predisposition. Certain changes in the endocrine system also have a role in the development of the striae. In this case, the stretch marks began when the patient started taking the Mercillon contraceptive pills and matured after she ceased to take the birth control pills and began a long-term daily application of tretinoin cream. While patients who are candidates for augmentation mammoplasty should be informed of the possible risk in taking OCs, there is no conclusive evidence that there is a relationship between the use of birth control pills and the development of striae distensae following augmentation mammoplasty. | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:meshHeading | pubmed-meshheading:10029486... | lld:pubmed |
| pubmed-article:10029486 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10029486 | pubmed:articleTitle | Striae distensae of augmented breasts after oral contraceptive therapy. | lld:pubmed |
| pubmed-article:10029486 | pubmed:affiliation | Plastic Surgery Unit, Carmel Medical Center, Haifa, Israel. | lld:pubmed |
| pubmed-article:10029486 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10029486 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10029486 | lld:pubmed |
